3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Gynecologic
1
Breast
1
Conditions
Carcinoma, Ovarian Epithelial
6
Uterine Cervical Neoplasms
5
Ovarian Neoplasms
5
Breast Neoplasms
5
Testicular Neoplasms
4
Precancerous Conditions
4
Neoplasms
4
Leukemia, Myeloid, Acute
4
Esophageal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Urinary Bladder Neoplasms
3
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Sezary Syndrome
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Mycosis Fungoides
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Hairy Cell
3
Hodgkin Disease
3
Fallopian Tube Neoplasms
3
Congenital Abnormalities
3
Burkitt Lymphoma
3
Interventions
pembrolizumab
2
Nivolumab
2
Carboplatin
2
tislelizumab
1
spartalizumab
1
ribociclib
1
obinutuzumab
1
naptumomab estafenatox
1
durvalumab
1
abemaciclib
1
Polymerase Chain Reaction
1
Mass Spectrometry
1
In Situ Hybridization, Fluorescence
1
Immunohistochemistry
1
Fulvestrant
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Polymerase Chain Reaction
×
Gynecologic
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled